Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MenoGeniX Logo
MenoGeniX CB Rank
141414
Heat Score
52
MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.
Founded
obfuscation
PrivateGrant Aurora, Colorado, United States1-10 www.menogenix.com/
Biotechnology
Medical
Medical Device
Overview

MenoGeniX
Total Funding
obfuscation
Heat Score
52

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 52
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MenoGeniX

CB Rank
141414
MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.
Founded
obfuscation
PrivateGrant Aurora, Colorado, United States1-10 www.menogenix.com/
Biotechnology
Medical
Medical Device

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name MenoGeniX, Inc.
Also Known As MenoGeniX Inc.
Operating Status Active
Company Type For Profit
Founders  Debra M. Duke, Douglas Farrar
About the Company
MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in 2010 and is based in Aurora, Colorado.
Phone Number +720-859-4080
Contact Email info@menogenix.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Products & Services

MNGX-100
A biopharmaceutical developed for treating moderate and severe hot flashes and other vasomotor symptoms in women undergoing natural or surgically induced menopause.
Phase I Clinical Trial
A completed multicenter, double-blind, randomized, placebo-controlled trial assessing MNGX-100's safety and effectiveness in women with menopause.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant
obfuscation
Grant - MenoGeniX Logo
Grant - MenoGeniX
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institutes of Health Logo
National Institutes of Health
—
Grant - MenoGeniX Logo
Grant - MenoGeniX
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - MenoGeniX Logo
Grant - MenoGeniX
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - MenoGeniX Logo
Grant - MenoGeniX
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - MenoGeniX Logo
Grant - MenoGeniX
—
National Institutes of Health Logo
National Institutes of Health
—
Grant - MenoGeniX Logo
Grant - MenoGeniX
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Contacts 1

Employee Profiles

News

News and Press

News•Mar 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 22, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 28, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 12, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$107.4KThis year, MenoGeniX is projected to spend $107.4K on IT, according to Aberdeen.

Actively Used Products

8MenoGeniX uses 8 technology products and services including HTML5, Google Fonts, and  Modernizr, according to G2 Stack.

Active Website Tech Count

16MenoGeniX is actively using 16 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

3The intellectual property of MenoGeniX includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is MenoGeniX's headquarters? MenoGeniX is located in Aurora, Colorado, United States.Who invested in MenoGeniX? MenoGeniX is funded by National Institutes of Health.When was the last funding round for MenoGeniX? MenoGeniX closed its last funding round on
obfuscation
from a Grant round.Who are MenoGeniX's competitors? Alternatives and possible competitors to MenoGeniX may include Bayer, Astellas Pharma, and  Universidad Nuevo Mundo, A.C..How much funding has MenoGeniX raised to date? MenoGeniX has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|